How many years can you live if prostate cancer spreads?

The survival period after prostate cancer spreads is usually 3-5 years. The actual time is related to the malignancy of the tumor, treatment plan, patient's physical condition and other factors. The main influencing factors include Gleason score, metastasis site, hormone treatment sensitivity, general health status and psychological state.

1. Gleason score:

Gleason score is a key indicator for assessing the malignancy of prostate cancer. The higher the score, the worse the prognosis. Intermediate and low-risk patients with a score of 7 or less may survive for more than 5 years with standard treatment, even if metastasis occurs. ； For high-risk patients with scores of 8-10, survival is often shortened to 2-3 years. Pathological biopsy can confirm this score.

2. Transfer site:

Bone metastasis is the most common condition, and the median survival time of patients is about 3 years.； If metastasis occurs to internal organs such as the liver and lungs, the survival period is usually reduced to 1-2 years. The prognosis of localized lymph node metastasis is relatively good, and some patients can survive for more than 5 years. PET-CT examination can accurately locate metastases.

3. Hormone treatment sensitivity:

About 80% of patients respond initially to androgen deprivation therapy, and the sensitive period can last for 18-24 months. After entering the castration resistance stage, new endocrine drugs such as abiraterone and enzalutamide can still prolong survival by 1-2 years. PSA levels need to be tested regularly during treatment.

4. General health status:

The survival time of patients with underlying diseases such as cardiovascular disease and diabetes is 30%-40% shorter than that of healthy people. Age is also an important factor, with patients under 70 years of age better tolerating chemotherapy. Patients with good nutritional status have a 15% improvement in five-year survival rate.

3. Mental state:

Patients who maintain a positive attitude extend their survival by an average of 6-8 months. Participating in psychological support groups and practicing moderate exercise such as Tai Chi and walking can improve the quality of life. Depression can reduce immune function and accelerate the progression of the disease.

It is recommended that patients maintain a high-protein diet such as fish and soy products, and supplement vitamin D 800IU daily. Moderate resistance training to maintain muscle mass, and brisk walking for 30 minutes three times a week can improve bone metastasis pain. Regularly monitor blood routine, liver and kidney function, and seek medical attention promptly if severe bone pain or difficulty urinating occurs. Pain management can include nonsteroidal anti-inflammatory drugs or low-dose opioids, and the specific medication regimen needs to be determined by the oncologist. Family members should pay attention to the patient's emotional changes and seek professional psychological intervention if necessary.